Low utility of CYFRA 21-1 serum levels for diagnosis and follow-up in bladder cancer patients

Journal of Clinical Laboratory Analysis

Volumn 19, Issue 4, 2005, Pages 167-171

  Fatela Cantillo, Daniel ^a   Fernández Suárez, Antonio ^a   Menéndez, Violeta ^b   Galán, Juan Antonio ^b   Filella, Xavier ^c  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Bladder cancer; CYFRA 21 1; Diagnosis; Follow up; Serum

Indexed keywords

CYTOKERATIN 19 FRAGMENT;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER RECURRENCE; CONCENTRATION RESPONSE; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; TRANSITIONAL CELL CARCINOMA;

EID: 23044473564     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcla.20072     Document Type: Article

References (20)

1. Messing EM. Urothelial tumors of the urinary tract. In: Walsh PC, Retik AB, Vauglin RD, et al., editors. Campbell's urology. 8th ed. Philadelphia: W.B. Saunders; 2002. p 2732-2773.
2. Newling DW. Preventing recurrence and progression in superficial bladder cancer. Curr Opin Urol 1996;6:272-279.
3. Badalament RA, Hemansen DK, Kimmel M, et al. The sensitivity of bladder cancer wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma. Cancer 1987;60:1423-1427.
4. Grossman HB. New methods for detection of bladder cancer. Semin Urol Oncol 1998;16:17-22.
5. Soloway MS. Do we have a prostate specific antigen for bladder cancer? J Urol 1999;161:447-448.
6. Oxen H, Craig-Hall M. Bladder cancer. Curr Opin Oncol 1999;11:207-212.
7. Ross JS, Cohen MB. Detecting recurrent bladder cancer: new methods and biomarkers. Expert Rev Mol Diagn 2001;1:39-52.
8. Fuchs E. Keratins as biochemical markers of epithelial dilferentiation. Trends Genet 1988;4:277-281.
9. Bodenmüller H. The biochemistry of CYFRA 21-1 and other cytokeratin-tests. Scand J Clin Lab Invest 1995;35:60-66.
10. American Joint Committee on Cancer. AJCC manual for staging of cancer. 3rd ed. Philadelphia: Lippincott-Raven Publishers; 1988. p 194-195.
11. Morita T, Kikuchi T, Hashimoto S, Kobayashi Y, Tokue A. Cytokeratin-19 fragment (CYFRA 21-1) in bladder cancer. Eur Urol 1997;32:237-244.
12. van der Gaast A, Schoenmakers CH, Kok TC, Blijenberg BG, Cornillie F, Splinter TA. Evaluation of a new tumor marker in patients with non-small cell lung cancer: CYFRA 21-1. Br J Cancer 1994;69:525-528.
13. Mady EA. Cytokeratins as serum markers in egyptian bladder cancer. A comparison of CYFRA 21-1, TPA and TPS. Int J Biol Markers 2001;16:130-135.
14. Stieber P, Schemeller N, Schambeck C, et al. Clinical relevance of CYFRA 21-1, TPA-IRMA and TPA-LIA-mat in urinary bladder cancer. Anticancer Res 1996;16:3793-3798.
15. Nisman B, Barak V, Shapiro A, Golijanin D, Peretz T, Pode D. Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma. Cancer 2002;94:2914-2922.
16. Pariente JL, Bordenave L, Jacob F, et al. Analytical and prospective evaluation of urinary cytokeratin 19 fragment in bladder cancer. J Urol 2000;163:1116-1119.
17. Dittadi R, Barioli P, Gion M, et al. Standardization of assay for cytokeratin-related tumor marker CYFRA 21-1 in urine samples. Clin Chem 1996;42:1634-1638.
18. Niklinski J, Furman M, Chyczewska E, Chyczewski E, Rogowski F, Laudanski J. Diagnostic and prognostic value of the new tumor marker CYFRA 21-1 in patients with squamous cell lung cancer. Eur Respir J 1995;8:291-296.
19. Sanchez-Carbayo M, Urrutia M, Silva JM, Romani R, De Buitrago JM, Navajo JA. Comparative predictive values of urinary cytology, urinary bladder cancer antigen. CYFRA 21-1 and NMP22 for evaluating symptomatic patients at risk for bladder cancer. J Urol 2001;165:1462-1467.
20. Maier U, Simak R, Neuhold N. The clinical value of urinary cytology: 12 years of experience with 615 patients. J Clin Pathol 1995;48:314-317.